Clincosm LogoSign in Get a demo

Serum Fetuin Level in Polycystic Ovary Syndrome

Sponsor
Aljazeera Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03819998
Collaborator
Cairo University (Other), National Research Centre, Egypt (Other)
50
Enrollment
1
Location
12.2
Anticipated Duration (Months)
4.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

polycystic ovary syndrome is a common gynecological problem

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: measurement of Fetuin-A level in serum

Detailed Description

Understanding the pathophysiology and the cause is of much importance for proper management of this problem

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Serum Fetuin Level as a Marker in Polycystic Ovary Syndrome
Actual Study Start Date :
Jan 30, 2019
Anticipated Primary Completion Date :
Feb 1, 2020
Anticipated Study Completion Date :
Feb 5, 2020

Arms and Interventions

Arm Intervention/Treatment
PCOS group

women who have PCOS

Diagnostic Test: measurement of Fetuin-A level in serum
Fetuin A level will be measured in blood of the PCOS women
Other Names:
  • Fwtuin A level

    		•
    control group

    women who donnot have PCOS

    Diagnostic Test: measurement of Fetuin-A level in serum
    Fetuin A level will be measured in blood of the PCOS women
    Other Names:
  • Fwtuin A level

    		•

    Outcome Measures

    Primary Outcome Measures

    1. The number of women who will have high level of fetuin A and has PCOS [within a week]

      Evaluation of women who have PCOS in relation to fetuin A level

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 42 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • women who have PCOS in group 1 and who donnot have PCOS in group 2 with age between 20 -42 years
    Exclusion Criteria:
    • women above 42 years old

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Algazeerah and Kasralainy hospital Giza Egypt

    Sponsors and Collaborators

    • Aljazeera Hospital
    • Cairo University
    • National Research Centre, Egypt

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Aljazeera Hospital
    ClinicalTrials.gov Identifier:
    NCT03819998
    Other Study ID Numbers:
    • Fetuin
    First Posted:
    Jan 29, 2019
    Last Update Posted:
    Aug 6, 2019
    Last Verified:
    Aug 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Polycystic Ovary Syndrome

    Study Results

    No Results Posted as of Aug 6, 2019